News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Berlin Heart AG's EXCOR(R) Pediatric Receives Conditional Investigational Device Exemption (IDE) Approval



5/16/2007 1:20:45 PM

Berlin Heart GmbH today announced its EXCOR® Pediatric ventricular assist device (VAD) has received conditional approval for IDE purposes in the United States of America. The U.S. Food and Drug Administration has granted conditional approval for the prospective IDE study to begin initially at 10 centres with 10 patients.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES